Insider

MEDP

Medpace Holdings Inc

Oct 17 • 04:00PM ET

528.07

+6.86 1.32 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: IQV CRL INCY LH ICON CTLT KOD FATE ALLO ONC

| Held by: IJH VTI VB XMHQ VBK VXF MDY IWP IBB IJK

Scroll to Statements

Index	-	P/E	39.27	EPS (ttm)	13.45	Insider Own	19.12%	Shs Outstand	28.02M	Perf Week	5.36%
Market Cap	14.84B	Forward P/E	33.97	EPS next Y	15.55	Insider Trans	-2.97%	Shs Float	22.72M	Perf Month	5.21%
Enterprise Value	14.94B	PEG	3.65	EPS next Q	3.53	Inst Own	95.39%	Short Float	9.14%	Perf Quarter	70.96%
Income	418.30M	P/S	6.65	EPS this Y	11.26%	Inst Trans	2.84%	Short Ratio	4.56	Perf Half Y	78.23%
Sales	2.23B	P/B	85.85	EPS next Y	10.63%	ROA	23.96%	Short Interest	2.08M	Perf YTD	58.95%
Book/sh	6.15	P/C	320.20	EPS next 5Y	10.77%	ROE	89.38%	52W High	547.15 -3.49%	Perf Year	49.47%
Cash/sh	1.65	P/FCF	25.59	EPS past 3/5Y	37.94% 36.50%	ROIC	140.70%	52W Low	250.05 111.19%	Perf 3Y	238.22%
Dividend Est.	-	EV/EBITDA	29.49	Sales past 3/5Y	22.68% 19.62%	Gross Margin	30.32%	Volatility	3.29% 3.01%	Perf 5Y	321.81%
Dividend TTM	-	EV/Sales	6.69	EPS Y/Y TTM	25.30%	Oper. Margin	21.40%	ATR (14)	15.52	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.43	Sales Y/Y TTM	9.94%	Profit Margin	18.74%	RSI (14)	58.78	Recom	3.50
Dividend Gr. 3/5Y	- -	Current Ratio	0.43	EPS Q/Q	12.47%	SMA20	2.29%	Beta	1.41	Target Price	448.20
Payout	0.00%	Debt/Eq	0.87	Sales Q/Q	14.24%	SMA50	7.46%	Rel Volume	0.38	Prev Close	521.21
Employees	5900	LT Debt/Eq	0.72	Earnings	Oct 22 AMC	SMA200	42.90%	Avg Volume	455.73K	Price	528.07
IPO	Aug 11, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.94% 11.98%	Trades		Volume	176,262	Change	1.32%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-02-25	Downgrade	Barclays	Equal Weight → Underweight	$425
Sep-03-25	Downgrade	Rothschild & Co Redburn	Buy → Neutral	$474
Jul-29-25	Downgrade	UBS	Neutral → Sell	$305
Jul-23-25	Downgrade	TD Cowen	Hold → Sell	$366
Jun-24-25	Initiated	Barclays	Equal Weight	$300
Apr-22-25	Downgrade	William Blair	Outperform → Mkt Perform
Apr-14-25	Downgrade	TD Cowen	Buy → Hold	$328
Mar-24-25	Initiated	Leerink Partners	Market Perform	$330
Oct-23-24	Downgrade	Robert W. Baird	Outperform → Neutral	$413 → $349
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-27-24	Downgrade	UBS	Buy → Neutral	$420 → $350
Sep-25-24	Downgrade	Jefferies	Buy → Hold	$415 → $345
Aug-01-24	Initiated	Truist	Hold	$415
May-29-24	Initiated	TD Cowen	Buy	$452
May-28-24	Initiated	Mizuho	Buy	$435
Apr-23-24	Upgrade	Jefferies	Hold → Buy	$340 → $450
Mar-18-24	Initiated	Deutsche Bank	Hold	$395
Feb-15-24	Upgrade	UBS	Neutral → Buy	$282 → $452
Oct-24-23	Upgrade	Robert W. Baird	Neutral → Outperform	$270 → $289
May-08-23	Upgrade	Guggenheim	Neutral → Buy	$252

Show Previous Ratings

Oct-17-25 10:18AM	Danaher Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock? (Zacks)
Oct-16-25 06:15PM	Medpace (MEDP) Rises As Market Takes a Dip: Key Facts (Zacks)
08:19AM	Should You be Excited about Medpace Holdings' (MEDP) Prospects? (Insider Monkey)
Oct-15-25 10:00AM	Medpace (MEDP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-14-25 09:57AM	Robust Booking Growth Boosted Medpace Holdings (MEDP) in Q3 (Insider Monkey)
06:15PM	Loading…
Oct-10-25 06:15PM	Medpace (MEDP) Dips More Than Broader Market: What You Should Know (Zacks) +5.22%
03:50PM	Medpace and Revvity Stocks Trade Down, What You Need To Know (StockStory)
08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Oct-09-25 12:10PM	Will Medpace (MEDP) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:48AM	Brookdale Posts Strong YoY Rise in September 2025 Occupancy (Zacks)
09:40AM	Is Medpace (MEDP) Outperforming Other Medical Stocks This Year? (Zacks)
08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Oct-07-25 12:30PM	Nyxoah Shares Rise on First U.S. Commercial Use of Genio System (Zacks)
Oct-06-25 10:16AM	ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment (Zacks)
Oct-05-25 11:32PM	Drug Development Inputs & Services Stocks Q2 Recap: Benchmarking Medpace (NASDAQ:MEDP) (StockStory)
11:40AM	Loading…
Oct-03-25 11:40AM	SOLV vs. MEDP: Which Stock Is the Better Value Option? (Zacks)
Oct-02-25 06:15PM	Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors (Zacks)
11:36AM	Why Medpace (MEDP) Stock Is Trading Lower Today (StockStory)
09:40AM	Nike upgraded, RH downgraded: Wall Street's top analyst calls (The Fly)
09:34AM	Life science tools Q3 preview: Barclays ups Charles River, downgrades Medpace (Investing.com)
Sep-29-25 08:07AM	HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis (Zacks)
Sep-25-25 06:15PM	Medpace (MEDP) Dips More Than Broader Market: What You Should Know (Zacks)
12:54PM	TMDX Partners With Mercedes-Benz to Launch Organ Transport Network (Zacks)
Sep-23-25 04:05PM	Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025 (Business Wire)
01:15PM	STXS Stock Gains as Erasmus Medical Adopts Its Genesis Robotic System (Zacks)
01:11PM	Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now (Zacks)
Sep-22-25 12:33PM	Stryker Expands R&D Facility in India to Boost Medtech Innovation (Zacks)
12:27PM	Reasons to Hold AngioDynamics Stock in Your Portfolio for Now (Zacks)
09:46AM	Reasons to Retain Cooper Companies Stock in Your Portfolio for Now (Zacks)
09:09AM	Take the Zacks Approach to Beat the Market: LendingTree, AutoZone, J&J in Focus (Zacks)
09:19AM	Loading…
Sep-19-25 09:19AM	Does Medpace Holdings (MEDP) Have a Long Runway For Growth? (Insider Monkey)
07:34AM	SGHT Shares Rise on Meta-Analysis Showing OMNI's Long-Term Benefits (Zacks)
Sep-18-25 10:14AM	Here's Why You Should Hold Accuray Stock in Your Portfolio for Now (Zacks)
10:05AM	SYK Partners With Siemens Healthineers to Boost Stroke, Aneurysm Care (Zacks)
08:42AM	Avanos Medical Buys Nexus Medical to Bolster Critical Care Portfolio (Zacks)
08:41AM	Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy (Zacks)
Sep-17-25 10:41AM	BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care (Zacks)
08:51AM	CAH Strengthens Distribution With New Consumer Health Logistics Hub (Zacks)
08:50AM	GEHC Expands Women's Health Portfolio With AI-Enabled Voluson (Zacks)
Sep-16-25 11:40AM	SOLV or MEDP: Which Is the Better Value Stock Right Now? (Zacks)
10:26AM	ISRG Stock Dips Despite Introducing Real-Time Insights on da Vinci 5 (Zacks)
09:34AM	GEHC Eyes icometrix Buyout to Strengthen Neurology Imaging Portfolio (Zacks)
Sep-15-25 06:15PM	Why Medpace (MEDP) Outpaced the Stock Market Today (Zacks)
12:34PM	MMSI Stock Falls Despite CE Mark Win for Embosphere in Knee OA Care (Zacks)
Sep-12-25 03:49AM	The Zacks Analyst Blog Highlights Hasbro, Robinhood Markets, Interactive Brokers, Celsius and Medpace (Zacks)
Sep-11-25 12:24PM	Pulse Biosciences Gets FDA IDE Nod for Atrial Fibrillation Study (Zacks)
12:20PM	Here's Why You Should Retain OPKO Health Stock in Your Portfolio (Zacks)
09:45AM	5 Non-Tech Nasdaq Stocks to Buy That Helped the Index Surge in 2025 (Zacks)
08:24AM	Reasons to Add West Pharmaceutical Stock to Your Portfolio Now (Zacks)
Sep-10-25 12:35PM	Reasons to Retain Avanos Medical Stock in Your Portfolio Now (Zacks)
09:02AM	Dentsply Sirona Retains Wellspect Following Strategic Review (Zacks)
Sep-09-25 01:25PM	Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System (Zacks)
08:45AM	Lifeward Achieves European Approval for Latest ReWalk Exoskeleton (Zacks)
Sep-08-25 07:34PM	Medpace (MEDP) Outpaces Stock Market Gains: What You Should Know (Zacks)
12:36PM	Cardinal Health Expands At-Home Solutions With New Texas Facility (Zacks)
08:14AM	MYGN Stock Might Gain on The Lancet Study Backing Precise MRD (Zacks)
08:07AM	GEHC Stock Gains Following Launch of Revolution Vibe CT Imaging System (Zacks)
Sep-05-25 12:30PM	PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq (Zacks)
11:31AM	Medpace Holdings, Inc. (MEDP): A Bull Case Theory (Insider Monkey)
10:56AM	MYGN's GeneSight Test Proven Superior to TAU: Stock to Gain? (Zacks)
08:06AM	Here's Why You Should Hold Cencora Stock in Your Portfolio Now (Zacks)
Sep-04-25 11:40AM	Here's Why You Should Retain Ecolab Stock in Your Portfolio Now (Zacks)
Sep-03-25 01:23PM	HealthEquity Stock Gains as Q2 Earnings Beat Estimates, Revenues Up Y/Y (Zacks)
08:50AM	STXS Launches First U.S. Robotic HD Mapping With MAGiC Sweep (Zacks)
Sep-02-25 01:32PM	IRTC Unveils Positive AMALFI Trial Data Showing Higher AF Detection (Zacks)
Sep-01-25 12:53PM	GEHC Launches AI-Powered Vivid Pioneer Cardiac Ultrasound System (Zacks)
09:54AM	ABT Stock Gains From Navitor's Expanded Indication Approval in Europe (Zacks)
09:51AM	FDA Identifies ICU Medical's Plum Duo Recall as Serious Type (Zacks)
Aug-29-25 12:24PM	Reasons to Retain TransMedics Stock in Your Portfolio for Now (Zacks)
09:47AM	Here's Why You Should Add CLOV Stock to Your Portfolio Now (Zacks)
09:47AM	COO Q3 Earnings Beat, 2025 Sales Outlook Lowered, Stock Down (Zacks)
Aug-28-25 11:40AM	COR vs. MEDP: Which Stock Is the Better Value Option? (Zacks)
10:24AM	VEEV Q2 Earnings & Revenues Beat Estimates, Margin Rises, Stock Up (Zacks)
08:14AM	PAHC Stock Surges on Q4 Earnings & Revenue Beat, Gross Margin Down (Zacks)
Aug-27-25 12:25PM	PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment (Zacks)
08:29AM	Here's Why You Should Retain CONMED Stock in Your Portfolio for Now (Zacks)
Aug-25-25 12:52PM	Natera Shares Rise on the Launch of AI Platform for Precision Oncology (Zacks)
Aug-22-25 01:30PM	BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care (Zacks)
12:03AM	2 Reasons to Watch MEDP and 1 to Stay Cautious (StockStory)
Aug-21-25 01:33PM	Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market (Zacks)
01:30PM	Reasons to Hold AngioDynamics Stock in Your Portfolio for Now (Zacks)
10:12AM	Alcon's Q2 Earnings Beat Estimates, Revenues Miss, Stock Plunges (Zacks)
Aug-20-25 01:24PM	Masimo Shares Dip Despite FDA Clears Expanded Use of O3 Monitoring (Zacks)
Aug-19-25 12:56PM	Health Care Stock Flashes Golden Cross As Sales Surge; Shares Hover Near Buy Point (Investor's Business Daily)
10:13AM	NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment (Zacks)
09:48AM	MDT Stock Falls Despite Q1 Earnings & Revenue Beat, FY26 EPS View Up (Zacks)
08:50AM	Cooper Companies' Innovation Fuels Growth Amid Macro Headwinds (Zacks)
Aug-18-25 12:00PM	Medpace (MEDP) Is Up 5.41% in One Week: What You Should Know (Zacks)
Aug-15-25 10:04AM	This Eye Treatment Stock Sees Sales Spike 152% As Biotech Leaders Shine (Investor's Business Daily)
Aug-14-25 02:50PM	Tempus AI Stock Scores Relative Strength Rating Upgrade (Investor's Business Daily)
11:17AM	Accuray Stock Down as Q4 Earnings Miss Estimates, Revenues Down Y/Y (Zacks)
11:05AM	Reasons to Hold HealthEquity Stock in Your Portfolio for Now (Zacks)
Aug-13-25 12:58PM	RGTI Stock Down Despite Q2 Earnings Top Estimates, Revenues Decline Y/Y (Zacks)
08:22AM	Globus Medical Stock Up on Q2 Earnings & Revenue Beat, Margins Expand (Zacks)
Aug-12-25 06:46PM	Analyst Report: Medpace Holdings, Inc. (Morningstar Research)
11:41AM	Reasons to Add Veeva Systems Stock to Your Portfolio for Now (Zacks)
10:37AM	CAH Q4 Earnings Beat Estimates, '26 EPS View Up, Stock Falls (Zacks)
08:27AM	EXAS Stock Dips Despite Q2 Earnings & Revenue Beat, '25 Sales View Up (Zacks)
08:25AM	Insulet Q2 Earnings & Revenues Beat Estimates, Stock Up, Margins Rise (Zacks)
08:22AM	EYE Stock Gains on Q2 Earnings and Revenue Beat, '25 View Up (Zacks)

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: United States, Europe, Belgium, Asia-Pacific, and Other. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BURWIG SUSAN E	Exec. VP, Operations	Sep 26 '25	Option Exercise	107.93	10,000	1,079,300	67,500	Sep 30 04:15 PM
BURWIG SUSAN E	Exec. VP, Operations	Sep 03 '25	Sale	480.00	10,000	4,800,000	57,500	Sep 05 04:16 PM
BURWIG SUSAN E	Officer	Sep 03 '25	Proposed Sale	480.00	10,000	4,800,019		Sep 03 04:49 PM
Troendle August J.	CEO	Aug 29 '25	Sale	475.90	36,196	17,225,676	925,799	Sep 03 04:10 PM
Troendle August J.	CEO	Sep 02 '25	Sale	475.11	1,197	568,707	924,602	Sep 03 04:10 PM
Troendle August J.	CEO	Aug 27 '25	Sale	475.00	620	294,500	961,995	Aug 28 04:23 PM
BURWIG SUSAN E	Exec. VP, Operations	Aug 26 '25	Option Exercise	107.93	10,000	1,079,300	67,500	Aug 28 04:10 PM
August J. Troendle	Chairman	Aug 27 '25	Proposed Sale	475.00	38,013	18,056,018		Aug 27 05:09 PM
McCarthy Cornelius P. III	Director	Aug 19 '25	Sale	465.04	1,662	772,896	10,197	Aug 21 04:56 PM
McCarthy Cornelius P. III	Director	Aug 19 '25	Proposed Sale	465.04	1,662	772,894		Aug 19 03:00 PM
EWALD STEPHEN P	General Counsel & Corp. Secy.	Jul 28 '25	Sale	450.00	3,000	1,350,000	10,343	Jul 29 06:02 PM
BURWIG SUSAN E	Exec. VP, Operations	Jul 28 '25	Sale	450.14	7,500	3,376,050	57,500	Jul 29 05:43 PM
Troendle August J.	CEO	Jul 28 '25	Sale	451.69	48,487	21,901,093	962,615	Jul 29 05:37 PM
GEIGER JESSE J	President	Jul 24 '25	Option Exercise	107.93	41,801	4,511,582	78,304	Jul 28 05:37 PM
GEIGER JESSE J	President	Jul 24 '25	Sale	453.11	41,801	18,940,451	36,503	Jul 28 05:37 PM
Brady Kevin M.	CFO & Treasurer	Jul 24 '25	Option Exercise	57.94	12,000	695,280	18,000	Jul 28 05:08 PM
Brady Kevin M.	CFO & Treasurer	Jul 24 '25	Sale	454.23	12,000	5,450,760	6,000	Jul 28 05:08 PM
BURWIG SUSAN E	Officer	Jul 28 '25	Proposed Sale	450.14	7,500	3,376,083		Jul 28 04:50 PM
August J. Troendle	Chairman	Jul 28 '25	Proposed Sale	451.68	356,446	161,001,311		Jul 28 04:35 PM
EWALD STEPHEN P	Officer	Jul 28 '25	Proposed Sale	450.00	3,000	1,350,000		Jul 28 03:27 PM
McCarthy Cornelius P. III	Director	Jul 22 '25	Option Exercise	54.99	1,972	108,440	11,859	Jul 24 04:31 PM
Brady Kevin M.	Officer	Jul 24 '25	Proposed Sale	454.23	12,000	5,450,751		Jul 24 04:13 PM
GEIGER JESSE J	Officer	Jul 24 '25	Proposed Sale	453.11	41,801	18,940,252		Jul 24 04:09 PM
McCarthy Cornelius P. III	Director	Jul 18 '25	Option Exercise	54.99	4,500	247,455	9,887	Jul 22 04:36 PM
DAVENPORT FRED B JR	Director	Apr 24 '25	Option Exercise	57.17	4,710	269,271	4,710	Apr 28 04:39 PM
DAVENPORT FRED B JR	Director	Apr 24 '25	Sale	301.82	1,712	516,716	2,998	Apr 28 04:39 PM
DAVENPORT FRED B JR	Director	Apr 24 '25	Proposed Sale	301.82	1,712	516,716		Apr 24 02:13 PM
Troendle August J.	CEO	Mar 07 '25	Option Exercise	68.62	356,446	24,458,835	1,011,102	Mar 10 05:47 PM
EWALD STEPHEN P	General Counsel & Corp. Secy.	Feb 27 '25	Buy	326.11	2	652	13,343	Feb 28 04:39 PM
Carley Brian T	Director	Feb 24 '25	Option Exercise	42.62	8,127	346,373	30,035	Feb 26 04:18 PM
Carley Brian T	Director	Feb 24 '25	Sale	345.59	4,003	1,383,397	26,032	Feb 26 04:18 PM
Carley Brian T	Director	Feb 24 '25	Proposed Sale	345.59	4,003	1,383,385		Feb 24 12:52 PM
GEIGER JESSE J	President	Dec 06 '24	Option Exercise	32.05	15,000	480,750	36,503	Dec 10 04:24 PM
BURWIG SUSAN E	Exec. VP, Operations	Nov 19 '24	Option Exercise	32.05	7,500	240,375	65,000	Nov 21 04:40 PM

MEDP

Medpace Holdings Inc

Upgrade your FINVIZ experience